Product Design & Development

Ex-drug distributor chairman convicted of fraud

By PAUL ELIAS - Associated Press Writer - Associated Press
Thursday, November 19, 2009

 Share
[-] Text [+]  
Loading...

Ex-drug distributor chairman convicted of fraud

A federal jury on Thursday found the former head of the country's largest drug distributor guilty of fraud, nearly 10 years after he played a central role in one of the costliest corporate accounting scandals of the time.

The jury convicted former McKesson Corp. chairman Charles McCall of four counts of securities fraud, plus a charge of evading corporate accounting controls. He was acquitted of a sixth charge accusing him of doctoring financial documents.

The jury also acquitted another top executive, former general counsel Jay Lapine, of any criminal wrongdoing for his involvement in McKesson's $12 billion acquisition of Atlanta-based HBO & Co. in January 1999.

A federal judge acquitted former McKesson finance chief Richard Hawkins after a trial in 2005. Four others, including former HBO president and later a McKesson executive vice president, pleaded guilty to charges of engineering a scheme to inflate HBO's revenues by $300 million to hide sales shortfalls and covering up the wrongdoing after the software maker was sold to McKesson, the country's largest drug distributor.

ADVERTISEMENT

McCall and Lapine first faced trial in 2006 when a jury deadlocked on most of the same charges.

McCall had been HBO chairman until the company was sold to McKesson in January 1999 for $12 billion. He briefly became chairman of the combined entity, which retained the McKesson name, before getting fired in June 1999 after the accounting scheme was uncovered.

Lapine briefly kept his job as general counsel after the merger, but was later fired.

After detecting the conspiracy, the San Francisco-based McKesson restated its financial results for 1998 and the first three months of 1999. When the restatement was announced in April 1999, McKesson's stock price plummeted 47 percent, costing investors $8.6 billion.

JOIN THE DISCUSSION
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

At Issue

Risky Business: Funding Medical Device Innovation
Rahul Sathe, Principal Mechanical Engineer, Surgical and Interventional Products, Cambridge Consultants
Extracting Nuggets from the Invention Mine
Tom Tuytschaevers, a member of our Patent Practice Group

Site Sponsors


Most Viewed

Videos & Webcasts

The Energy Miser Concept Home 2/8/2012
Lower energy bills while making the house more comfortable, quieter, and safer? Who cares when you're demonstrating a completely Apple-based home control and automation system.   Continue
Inside the Audi A7 2/8/2012
When you take a look at the GPS system, you see real-time Google Earth 3D image navigation rather than cartoon-colored maps. It also powers the night vision system which includes a thermal camera to help detect pedestrians.   Continue
Engineering Mind Challenge Solved 2/8/2012
Dan and Vince find the solution to last week’s question "will the fan blade hit me if I try to stick my head between the spinning blades?"   Continue

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter